Author: oncologs.com

An interview with Eric J. Topol, MD, a world-renowned cardiologist, best-selling author of several books on personalized medicine, and the founder and director of the Scripps Research Translational Institute in La Jolla, California, has been published. in the new peer-reviewed journal, AI in Precision Oncology.

“We conducted a comprehensive investigation into the potential of XRCC1 as a valuable diagnostic and prognostic indicator in diverse cancer types.” Credit: 2024 Wang et al. “We conducted a comprehensive investigation into the potential of XRCC1 as a valuable diagnostic and prognostic indicator in diverse

Although the interior of São Paulo state (Brazil) has higher human development indices (HDIs) and fewer Black people as a percentage of the population, they account for a larger proportion of deaths from cancer in the Barretos region than in São Paulo city, the state

New research from Memorial Sloan Kettering Cancer Center (MSK) provides insights into how BRCA2 promotes genomic integrity; illuminates how embryonic cells can develop without key amino acids; explores how the microbiome bounces back after antibiotic treatment; and investigates acquired resistance to immunotherapy in non-small cell

For over three decades, a highly accurate early diagnostic test for ovarian cancer has eluded physicians. Now, scientists in the Georgia Tech Integrated Cancer Research Center (ICRC) have combined machine learning with information on blood metabolites to develop a new test able to detect ovarian

A new technology to increase visibility of cancer cells to the immune system using CRISPR has been developed, and could lead to a new way to treat cancer. Credit: Xin Sun, et al. Proceedings of the National Academy of Sciences. January 29, 2024 A new

Philadelphia, January 29, 2024 – Acute lymphoblastic leukemia (ALL) is the most common childhood cancer, representing more than 30% of all pediatric cases. A pilot study in The Journal of Molecular Diagnostics, published by Elsevier, confirms the feasibility of implementing an RNA sequencing analysis (RNA-Seq)

Researchers at OU Health Stephenson Cancer Center at the University of Oklahoma Health Sciences have embarked on a revolutionary new research study that could improve the detection of a deadly disease — pancreatic cancer — and give patients a chance to live longer, healthier lives.

Huntsman Cancer Institute at the University of Utah (the U) has received a $20 million land donation from the developers of Utah City, a new walkable mixed-use city center. This significant contribution from Woodbury Corporation and Flagship Companies, in partnership with the City of Vineyard,

JANUARY 23, 2024, NEW YORK – A Ludwig Cancer Research study has found that the circadian clock—which synchronizes physiological and cellular activities with the day-night cycle and is generally thought to be tumor suppressive—in fact has a contextually variable role in cancer. Credit: Ludwig Cancer